Lutropin-choriogonadotropic hormone receptor
Cross-source identity
Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.
This review treats Lutropin-choriogonadotropic hormone receptor as ChEMBL target CHEMBL2456, mapped to UniProt P16235. Disease framing currently uses the Open Targets-ready proxy contract.
Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.
Why Lutropin-choriogonadotropic hormone receptor matters
Lutropin-choriogonadotropic hormone receptor is reviewed as Lutropin-choriogonadotropic hormone receptor (UniProt P16235); the current evidence base includes 1 approved drug, 87 compounds, and 28 assays, with lead potency reaching pChEMBL 10.7.
Lutropin-choriogonadotropic hormone receptor Sequence length is 700 aa.
Review this target as Lutropin-choriogonadotropic hormone receptor, mapped to UniProt P16235. Sequence length is 700 aa.
Protein source · UniProt accession via ChEMBL component mappingDisease relevance is not yet populated for this evidence card.
This disease block keeps the Open Targets-ready contract explicit while current evidence comes from ChEMBL mechanism and indication mappings.
ChEMBL target recordChEMBL currently tracks 1 approved drug, 87 compounds, and 28 assays for this target. The dominant activity type is KI. CHEMBL412984 is the current potency anchor at pChEMBL 10.7.
Use CHEMBL412984 as the tractability anchor when discussing potency (pChEMBL 10.7).
Activity source · ChEMBL 36 via Core EngineStart with the right source
Pick the first block or linked source that matches the review question in front of you.
Start with the review rationale when you need to explain why Lutropin-choriogonadotropic hormone receptor matters before drilling into raw source blocks.
Jump to Review RationaleGo back to the target snapshot when you need the naming and mapping contract behind UniProt P16235, not just the summarized rationale.
Open Protein ContextUse the target snapshot disease block when you need the disease program and supporting signals, not only the card summary.
Open Disease ContextSnapshot State
No project snapshot selected. Export uses the live evidence card state.
pChEMBL Activity Distribution
Top 5 Inhibitors (by pChEMBL)
| Structure | Compound | pChEMBL | Type | Phase |
|---|---|---|---|---|
|
|
No preferred name
CHEMBL412984
|
10.7 | Ki | — |
|
|
No preferred name
CHEMBL407606
|
10.6 | Ki | — |
|
|
No preferred name
CHEMBL407123
|
10.4 | Ki | — |
|
|
No preferred name
CHEMBL405737
|
10.1 | Ki | — |
|
|
No preferred name
CHEMBL385042
|
10.0 | Ki | — |
Approved Drugs
| Structure | Compound | First Approval |
|---|---|---|
|
|
GONADORELIN
CHEMBL1007
|
1982 |